GIFT Nifty pointed to a firm opening for Indian equities, reflecting supportive global cues and steady investor sentiment. Asian markets showed mixed trends, while US indices remained strong, indicating a broadly constructive backdrop for risk assets.
Medi Assist Healthcare Services Ltd reported robust consolidated performance for 9MFY26, driven by revenue growth, balance-sheet strengthening, and technology-led efficiencies. Total income increased 23.5% YoY to ₹680 crore, with revenue from contracts rising 24% YoY to ₹662.8 crore. EBITDA stood at ₹126.3 crore, while margins were 19.1%. The company achieved a major milestone by turning debt-free in January 2026, reducing debt sharply from ₹243.4 crore (Sep’25) to ₹39.4 crore (Dec’25) and maintaining a free cash position of ₹200.1 crore.
Operationally, Premium Under Management grew 21.9% YoY to ₹19,289 crore, while overall Group + Retail market share improved to 21.1% (+133 bps) and Group share rose to 32.2% (+307 bps). The company serves 39+ crore lives annually and processed 72.9 lakh claims, reflecting 22.4% growth.
Paramount integration is progressing with technology consolidation and AI deployment across clients. The slump transfer of Paramount TPA business became effective February 1, 2026, accelerating synergies, while Paramount standalone EBITDA margins improved 557 bps QoQ.
Growth remained broad-based across segments: Group PUM rose 24.2%, Retail PUM 26.5%, Government revenue grew 45.9% in Q3, and International Benefits Administration expanded 16.3% YoY. The technology business remained a key driver, with proprietary tech revenue rising 81.5% YoY, and fraud detection platform MAven Guard identifying nearly ₹400 crore fraud.
Other Corporate Updates:
Radiant Cash Management Services Ltd will host its Q3FY26 earnings conference call on February 12, 2026, with senior management discussing financial performance and outlook.
Cipla Ltd announced the conclusion of a GST Department inspection in Maharashtra on February 7, 2026, confirming no material impact on financials or operations.
Godrej Agrovet launched ‘TAKAI’ insecticide for rice crops, powered by Cyclapryn technology, targeting major pests and aiming to improve crop yields. The product is also seeking approvals across multiple crops including maize, soybean, and sugarcane.
Global Market Snapshot (Feb 9, 2026):
GIFT Nifty: +0.94%, indicating a positive start for Indian markets.
US markets remained strong with S&P 500 +1.97% and Nasdaq +2.25%, while in Asia Nikkei surged 4.75%, though Hang Seng and Shanghai Composite declined modestly.
